Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus versus cyclosporine in de novo renal transplant recipients
2004-000973-69Phase 3Completed
- Sponsor
- Wyeth
- Start
- Feb 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in kidney transplant comparing Sirolimus regimen with Cyclosporine regimen (2 arms). Primary endpoints: Renal function at 52 weeks and Superiority of sirolimus regimen versus cyclosporine regimen. Started Feb 2005; status: completed.
02
Drugs
sirolimuscyclosporine
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2004-000973-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000973-69.